Flow Cytometry Laboratory Shared Resource
流式细胞术实验室共享资源
基本信息
- 批准号:9756883
- 负责人:
- 金额:$ 0.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesBiological AssayBiometryCancer CenterCancer Center Support GrantCell SeparationCellsComplexComprehensive Cancer CenterComputer HardwareComputer softwareConsultConsultationsCustomCytometryDataData AnalysesData SetEducationEducational workshopEnsureEtiologyFacultyFeedbackFlow CytometryFluorescenceFundingFutureGenerationsImage CytometryInformaticsKnowledgeLaboratoriesLaboratory PersonnelMalignant NeoplasmsMissionMonitorNCI Center for Cancer ResearchPopulationPreventionProceduresReagentReproducibilityResearchResearch SupportResource SharingScheduleServicesSorting - Cell MovementStrategic PlanningTechnologyTrainingUniversitiesVendorWisconsinbasecancer therapycostcost effectivedata acquisitiondesignexperimental studyfluorophoreinformatics shared resourceinstrumentinstrumentationknowledge basememberoperationprogramssuccess
项目摘要
PROJECT SUMMARY / ABSTRACT
The Flow Cytometry Laboratory (FLOW) was established by the UWCCC in 1988 to provide state-of-the-art
instrumentation and expertise that enables our members to acquire and analyze complex data sets on single
cells and cell populations and to isolate defined cell populations for further study.
In the current CCSG funding
cycle, FLOW has supported the research of 137 unique UWCCC members representing all 6 of our scientific
programs.
We have acquired new instrumentation, increased our capacity, established new services, and
expanded our educational programs directed to UWCCC members, their trainees, and staff. We have engaged
UWCCC leaders and our Scientific Advisory Committee to develop a strategic plan that will enable us to
continue to excel in our mission and meet the rapidly evolving research needs of UWCCC members. Over the
course of the next funding cycle we will achieve the following aims. Specific Aim 1 is to provide UWCCC
members access to state-of-the-art instrumentation for single cell analytics and sorting. FLOW houses,
operates, and maintains the broad assortment of instruments required for multi-parameter analytical cytometry,
imaging cytometry, and cell sorting. FLOW has established Standard Operating Procedures (SOPs) that
ensure all instruments are properly calibrated and operated in the manner required to yield high quality
datasets that achieve accepted standards for experimental rigor and reproducibility. Specific Aim 2 is to
provide expertise required for acquisition and analysis of multi-parameter flow cytometry data. Cell analytics
and sorting technologies are advancing rapidly, and FLOW leaders monitor these advances and strive to
ensure UWCCC members are able to fully exploit the newest technologies in their research. FLOW staff are
experts in developing reagent panels that enable members to utilize our instruments to collect multi-parameter
datasets with minimal spectral overlap. In addition, FLOW is developing a collaborative initiative with our
Biostatistics and Cancer Informatics Shared Resources to ensure that the multi-parameter datasets generated
on our instruments have appropriate power for robust statistical and informatics analyses. Specific Aim 3 is to
provide expert consultation and education services that enable our users to take full advantage of our
capabilities in single cell analytics and cell sorting. FLOW staff members consult with users to help them
optimize assay design, data acquisition, data analysis, and data presentation. We provide guidance on
instrument selection and operation. We inform users on incorporating appropriate technical controls into their
experiments. FLOW offers regularly scheduled didactic courses and hands-on training to our users to advance
their knowledge of flow cytometry and enhance their ability to perform high quality research at the lowest
possible cost. FLOW organizes seminars, workshops, and vendor presentations that expand the knowledge
base of our users. Support from the CCSG will enable us to continue to provide high level, cost-effective
services to UWCCC members and thereby advance the UWCCC research mission.
项目摘要 /摘要
UWCCC于1988年建立了流式细胞仪实验室(流),以提供最新的
仪器和专业知识,使我们的成员能够在单一中获取和分析复杂的数据集
细胞和细胞群,并分离定义的细胞群以进行进一步研究。
在当前的CCSG资金中
周期,流量支持了137名独特的UWCCC成员的研究,代表了我们所有6个科学的研究
程序。
我们已经获得了新的工具,提高了我们的能力,建立了新服务,并且
扩大了我们针对UWCCC成员,他们的学员和员工的教育计划。我们订婚了
UWCCC领导者和我们的科学咨询委员会制定战略计划,该计划将使我们能够
继续在我们的任务中表现出色,并满足UWCCC成员迅速发展的研究需求。在
在下一个资金周期的过程中,我们将实现以下目标。特定目标1是提供UWCCC
成员可以访问用于单细胞分析和分类的最先进的仪器。流房,
操作并保持多参数分析细胞仪所需的各种仪器,
成像细胞仪和细胞分类。流已经建立了标准操作程序(SOP)
确保所有乐器都经过适当的校准,并以高质量的方式进行操作
达到实验性严格和可重复性的公认标准的数据集。具体目标2是
提供获得和分析多参数流式细胞术数据所需的专业知识。细胞分析
分类技术正在迅速发展,流动领导者监视这些进步,并努力
确保UWCCC成员能够在其研究中充分利用最新技术。流人员是
开发试剂面板的专家,使成员能够利用我们的工具收集多参数
具有最小光谱重叠的数据集。此外,Flow正在与我们的合作计划发展
生物统计学和癌症信息学共享资源,以确保生成多参数数据集
在我们的工具上,具有适当的统计和信息分析的能力。具体目标3是
提供专家咨询和教育服务,使我们的用户能够充分利用我们的
单细胞分析和细胞分选的功能。流动人员咨询用户以帮助他们
优化测定设计,数据采集,数据分析和数据显示。我们提供有关
仪器选择和操作。我们通知用户将适当的技术控制纳入他们的
实验。 Flow为我们的用户提供定期安排的教学课程和动手培训
他们对流式细胞术的了解并增强了他们以最低的方式进行高质量研究的能力
可能的成本。 Flow组织研讨会,研讨会和供应商演讲,以扩大知识
我们用户的基础。 CCSG的支持将使我们能够继续提供高水平,具有成本效益的
为UWCCC成员提供服务,从而推进UWCCC研究任务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manish S Patankar其他文献
Manish S Patankar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manish S Patankar', 18)}}的其他基金
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer
使用化学生物学方法开发用于治疗卵巢癌的新型线粒体氧化磷酸化抑制剂
- 批准号:
10260915 - 财政年份:2022
- 资助金额:
$ 0.59万 - 项目类别:
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer
使用化学生物学方法开发用于治疗卵巢癌的新型线粒体氧化磷酸化抑制剂
- 批准号:
10513296 - 财政年份:2022
- 资助金额:
$ 0.59万 - 项目类别:
Developing non-human primate models for ovarian cancer
开发卵巢癌的非人类灵长类动物模型
- 批准号:
10044729 - 财政年份:2020
- 资助金额:
$ 0.59万 - 项目类别:
Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125)
通过监测免疫细胞结合 MUC16 (CA125) 诊断卵巢癌
- 批准号:
8123435 - 财政年份:2010
- 资助金额:
$ 0.59万 - 项目类别:
相似国自然基金
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:42207312
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
- 批准号:
- 批准年份:2020
- 资助金额:60 万元
- 项目类别:面上项目
硫酸盐还原菌生物膜活性的原位快速测定研究
- 批准号:41876101
- 批准年份:2018
- 资助金额:62.0 万元
- 项目类别:面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
- 批准号:81803848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
ELUCIDATING THE ROLE OF COATOMER COMPLEX COPI IN SKELETAL DYSPLASIA
阐明 COATOMER 复合物 COPI 在骨骼发育不良中的作用
- 批准号:
10591042 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Using natural killer cells to prevent breast cancer metastases
使用自然杀伤细胞预防乳腺癌转移
- 批准号:
10591362 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Delineating the Genetic Susceptibility of Smoking-Induced Vascular Dysfunction
描述吸烟引起的血管功能障碍的遗传易感性
- 批准号:
10852366 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
CF 2: Biostatistics and Bioinformatics Core
CF 2:生物统计学和生物信息学核心
- 批准号:
10932619 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别:
Defining the Role of Retinal Microglia and Infiltrating Monocytes on Photoreceptor Cell Death in Retinal Detachment
定义视网膜小胶质细胞和浸润单核细胞对视网膜脱离感光细胞死亡的作用
- 批准号:
10644354 - 财政年份:2023
- 资助金额:
$ 0.59万 - 项目类别: